Mulugeta Gebregziabher, Ph.D., a nationally and internationally recognized public health leader, researcher and educator, has been named a professor and the endowed chair of the Department of Biostatistics and Epidemiology at the University of Oklahoma Hudson College of Public Health.

The University of Oklahoma College of Medicine has been awarded a five-year, $10.7 million grant from the National Institutes of Health to create the Oklahoma Center for Biomedical Research Excellence in Sensory Biology. The center will serve as a hub for research into how cells sense and respond to their environment and the diseases that can occur when that process malfunctions.

The University of Oklahoma recently hosted its inaugural Real-World Data and Observational Health Data Sciences and Informatics training workshop through the Office of Clinical Research Informatics and the Biomedical and Behavioral Methodology Core, bringing together a multidisciplinary group of clinical and data scientists from across the university's three major campuses in Norman, Oklahoma City and Tulsa. The workshop was designed to build institutional capacity for conducting large-scale real-world evidence research using the international OHDSI network.

Beginning July 1, physicians from the University of Oklahoma College of Medicine Department of Emergency Medicine will provide medical direction to the Oklahoma Poison Center, a free, 24/7 helpline administered by the OU College of Pharmacy. The physicians, who have specialty training in medical toxicology, will be available to consult with the pharmacists and registered nurses who staff the helpline, as well as participate in educational, research and administrative activities.

Muhammad Furqan, M.D., professor of hematology-oncology at the University of Oklahoma College of Medicine and Associate Director of Clinical Research at OU Health Stephenson Cancer Center, is leading a national clinical trial evaluating whether immunotherapy can improve outcomes for patients with stage I non-small cell lung cancer (NSCLC) following surgery.